1. Scrip
  2. >>Business

Podcast: Organon APAC Head On Why World Needs A Company Dedicated To Women’s Health

 
• By Anju Ghangurde

In this audio interview, Organon’s head for the Asia Pacific region talks to Scrip on the company’s ambitions in the women’s health segment and the outlook for its biosimilars and established brands portfolios.

Scrip Podcast Special
organon's APAC head talks to Scrip in an audio interview

Kaja Natland, Organon’s head for the Asia Pacific region including Japan, tells Scrip why the world needs a specialist women’s health company, underscoring there’s no other healthcare firm with the kind of global footprint that the Merck & Co., Inc. spin-out brings and which is dedicated to “putting women at the center.”

Currently, Organon’s portfolio comprises over 60 medicines and products that cater to more than 140 markets, with about 80% of its $6.5bn in global revenues coming from outside the US

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.